NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Navin Fluorine International Reports Highest-Ever Quarterly Revenue

Navin Fluorine International Ltd (NFIL) has announced its highest-ever quarterly revenue of Rs9.4bn, marking a robust growth of 33.8% year-over-year (YoY) and 1% quarter-over-quarter (QoQ). This strong performance can be attributed to healthy momentum across all three business segments.

The HighPerformance Products (HPP) segment recorded a 20% YoY growth, driven by strong demand, improved realizations, and higher volumes. Additionally, commercial supplies of AHF commenced during Q4FY26, providing further growth opportunities. The Specialty Chemicals segment delivered a robust 39% YoY increase, with a strong product pipeline and solid order visibility already secured for FY27. The CDMO segment witnessed a strong performance, registering 61% YoY growth with 98% of its revenue driven by exports, aided by the commencement of commercial supplies from Phase 1 of cGMP4.

SegmentYoY Growth (Q4FY26)QoQ Growth (Q4FY26)
HighPerformance Products (HPP)20%N/A
Specialty Chemicals39%N/A
CDMO61%N/A

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

With a healthy order book extending over the next three years, management has reiterated confidence in sustained growth momentum for the company. The stock trades at 35x FY28E EPS, while we value the company at 38x FY28E EPS, arriving at a target price of Rs7,297. We maintain our 'Accumulate' rating on the stock, supported by a strong order pipeline, ongoing capacity expansion, and debottlenecking initiatives that are expected to sustain growth.

Investor Takeaway

Investors should consider Navin Fluorine International Ltd for its robust growth and healthy order book.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.